A recent Nature Genetics paper by the Aceto and Beerenwinkel groups reveals clonal heterogeneity in circulating tumor cell clusters, advancing our understanding of metastasis-relevant clonal dynamics.
Filden & Siegner et al. used CRISPRi screens to map genetic interactions among core DNA damage response genes, revealing key mechanisms of genome stability and uncovering vulnerabilities with potential for cancer therapy.
Dr. Giorgia Scapin, former Chief Scientific Officer at Garuda Therapeutics (Cambridge, USA) will give a seminar on Wednesday, May 7th, 2025, at 12, in the seminar room HPL D32. Seminar is entitled "Discovery and Development of Transgene-Free Long-Term Hematopoietic Stem Cells". Guests are welcome!